SeouLin Bioscience: A Leading South Korean Provider of Research Tools and Diagnostics
SeouLin Bioscience, a prominent South Korean company specializing in research tools and diagnostics, continues to expand its portfolio and strengthen its position within the rapidly evolving biotechnology and healthcare landscape. Founded over three decades ago, the company has become a key supplier to research institutions and clinical laboratories, offering a diverse range of products and services. Recent developments, including new partnerships and product launches, signal a period of growth and innovation for SeouLin Bioscience as it navigates the complexities of the global life sciences market. The company, headquartered in Seongnam, Gyeonggi Province, is playing an increasingly important role in advancing scientific discovery and improving healthcare outcomes in South Korea and beyond.
Established in 1993, SeouLin Bioscience has evolved from a distributor of scientific equipment to a comprehensive solutions provider. The company’s core business revolves around the distribution and support of cutting-edge technologies used in biomedical research, drug discovery and clinical diagnostics. They represent several international brands, bringing innovative tools to the Korean market, while also developing and launching their own proprietary products. This dual approach allows SeouLin Bioscience to cater to a broad spectrum of customer needs, from basic research to advanced clinical applications. The company’s commitment to quality and customer service has been instrumental in building long-term relationships with leading universities, hospitals, and research centers throughout South Korea.
Company Overview and Leadership
SeouLin Bioscience operates from two primary locations: its headquarters in Seongnam, Gyeonggi Province, situated within the Korea Bio Park (700 Daewangpangyo-ro, Sampyeong-dong), and the SeouLin Global Center in Hwaseong, Gyeonggi Province (593-16 Dongtan-giheung-ro, Yeongcheon-dong). The company is jointly led by CEOs Hwang Eul-moon and Kang Mi-ok. Its business registration number is 213-86-04488. SeouLin Bioscience can be reached by phone at 1670-5911, and inquiries can be directed via email. A dedicated email address is also available for collaboration and dealer-related communications.
Recent Developments and Product Launches
SeouLin Bioscience has been actively expanding its product offerings and forging strategic partnerships in recent months. On March 3, 2026, the company announced a memorandum of understanding (MOU) with the Korean Society for Feline Medicine to collaborate on infectious disease prevention. SeouLin Bioscience also launched a new service on February 26, 2026, capable of analyzing over 7,000 protein types from a single blood sample, a significant advancement in proteomic research.
In January 2026, SeouLin Bioscience secured domestic sales rights for Bio-Rad Laboratories, a global leader in life science research and clinical diagnostics. This partnership will allow SeouLin Bioscience to offer a wider range of high-quality products to its customers. In December 2025, the company installed the first FACSDiscover™ A8 next-generation flow cytometer from BD Biosciences in South Korea, initially at Yonsei University and Hanyang University, marking a significant milestone in advanced cell analysis capabilities within the country. The company currently distributes products from Revvity, including AlphaLISA™ and HTRF®, as well as ELISA kits from Cell Signaling Technology (CST). They also offer the BD FACSDiscover™ Series, known for its innovative combination of spectral analysis and real-time imaging.
Product Portfolio and Key Offerings
SeouLin Bioscience’s product portfolio is extensive, encompassing a wide range of research tools and diagnostic solutions. Key product categories include:
- AlphaLISA™ and HTRF®: Highly sensitive biochemical assays for drug discovery and basic research.
- BD FACSDiscover™ Series: Advanced flow cytometry systems for cell analysis.
- CST ELISA Kits: Enzyme-linked immunosorbent assays for protein quantification.
- InVitria: Recombinant albumin-based solutions for biopharmaceutical applications.
- Nova Biomedical OsmoTECH: Osmolality measurement systems.
- Bio-Rad Products: A comprehensive range of life science research and clinical diagnostic tools.
- Latex Gloves: Newly launched biosafety gloves.
The company also provides a variety of support services, including technical assistance, training, and application support, ensuring that customers can effectively utilize their products and achieve optimal results. SeouLin Bioscience’s commitment to providing comprehensive solutions extends beyond simply selling products; they aim to be a trusted partner in their customers’ research and diagnostic endeavors.
Commitment to Innovation and Collaboration
SeouLin Bioscience demonstrates a strong commitment to innovation and collaboration. The MOU with the Korean Society for Feline Medicine highlights the company’s dedication to addressing emerging health challenges and contributing to veterinary medicine. The launch of the 7,000-protein analysis service underscores their investment in cutting-edge technologies and their ability to provide advanced diagnostic capabilities. By partnering with leading international companies like Bio-Rad and BD Biosciences, SeouLin Bioscience ensures that its customers have access to the latest advancements in life science research and clinical diagnostics.
The company’s focus on customer satisfaction and its dedication to providing high-quality products and services have established it as a trusted partner for researchers and clinicians throughout South Korea. SeouLin Bioscience continues to invest in its infrastructure, expand its product portfolio, and strengthen its collaborations to meet the evolving needs of the biotechnology and healthcare industries.
Looking Ahead
SeouLin Bioscience is well-positioned for continued growth and success in the dynamic South Korean biotechnology market. The company’s strong leadership, diverse product portfolio, and commitment to innovation will be key drivers of its future performance. Ongoing promotional activities, such as the EndNote webinar scheduled for March 20, 2026, and the CST ELISA Kit discount offered in January 2026, demonstrate their dedication to providing value to their customers. As the demand for advanced research tools and diagnostic solutions continues to increase, SeouLin Bioscience is poised to play an increasingly important role in advancing scientific discovery and improving healthcare outcomes in South Korea and beyond. Further updates on the company’s activities and product launches can be found on their official website.
The company will continue to focus on expanding its partnerships and introducing innovative products to the Korean market. The next major event to watch for is the ongoing EndNote webinar series, providing valuable training resources for researchers. We encourage readers to share their thoughts and experiences with SeouLin Bioscience products and services in the comments below.
Keep reading